Your browser doesn't support javascript.
loading
Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.
Muranen, Taru A; Khan, Sofia; Fagerholm, Rainer; Aittomäki, Kristiina; Cunningham, Julie M; Dennis, Joe; Leslie, Goska; McGuffog, Lesley; Parsons, Michael T; Simard, Jacques; Slager, Susan; Soucy, Penny; Easton, Douglas F; Tischkowitz, Marc; Spurdle, Amanda B; Schmutzler, Rita K; Wappenschmidt, Barbara; Hahnen, Eric; Hooning, Maartje J; Singer, Christian F; Wagner, Gabriel; Thomassen, Mads; Pedersen, Inge Sokilde; Domchek, Susan M; Nathanson, Katherine L; Lazaro, Conxi; Rossing, Caroline Maria; Andrulis, Irene L; Teixeira, Manuel R; James, Paul; Garber, Judy; Weitzel, Jeffrey N; Jakubowska, Anna; Yannoukakos, Drakoulis; John, Esther M; Southey, Melissa C; Schmidt, Marjanka K; Antoniou, Antonis C; Chenevix-Trench, Georgia; Blomqvist, Carl; Nevanlinna, Heli.
Afiliação
  • Muranen TA; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
  • Khan S; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
  • Fagerholm R; University of Turku and Åbo Akademi University, Turku Bioscience Centre, Turku, Finland.
  • Aittomäki K; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
  • Cunningham JM; University of Helsinki, Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland.
  • Dennis J; Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN USA.
  • Leslie G; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
  • McGuffog L; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
  • Parsons MT; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
  • Simard J; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia.
  • Slager S; CHU de Quebec Research Center, Genomics Center, Québec City, QC Canada.
  • Soucy P; Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA.
  • Easton DF; CHU de Quebec Research Center, Genomics Center, Québec City, QC Canada.
  • Tischkowitz M; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
  • Spurdle AB; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.
  • Schmutzler RK; University of Cambridge, Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK.
  • Wappenschmidt B; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia.
  • Hooning MJ; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.
  • Singer CF; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.
  • Wagner G; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Thomassen M; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.
  • Pedersen IS; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
  • Domchek SM; Erasmus MC Cancer Institute, Department of Medical Oncology, Family Cancer Clinic, Rotterdam, The Netherlands.
  • Lazaro C; Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria.
  • Rossing CM; Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria.
  • Andrulis IL; Odense University Hospital, Department of Clinical Genetics, Odence C, Denmark.
  • Teixeira MR; Aalborg University Hospital, Molecular Diagnostics, Aalborg, Denmark.
  • James P; Aalborg University, Dept of Clinical Medicine, Aalborg, Denmark.
  • Garber J; Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA.
  • Weitzel JN; Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA.
  • Jakubowska A; Rigshospitalet, Copenhagen University Hospital, Center for Genomic Medicine, Copenhagen, Denmark.
  • Yannoukakos D; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON Canada.
  • John EM; University of Toronto, Department of Molecular Genetics, Toronto, ON Canada.
  • Southey MC; Portuguese Oncology Institute, Department of Genetics, Porto, Portugal.
  • Schmidt MK; University of Porto, Biomedical Sciences Institute (ICBAS), Porto, Portugal.
  • Antoniou AC; Peter MacCallum Cancer Center, Parkville Familial Cancer Centre, Melbourne, VIC Australia.
  • Chenevix-Trench G; The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC Australia.
  • Blomqvist C; Dana-Farber Cancer Institute, Cancer Risk and Prevention Clinic, Boston, MA USA.
  • Nevanlinna H; City of Hope, Clinical Cancer Genomics, Duarte, CA USA.
NPJ Breast Cancer ; 6: 44, 2020.
Article em En | MEDLINE | ID: mdl-32964118
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Finlândia